The ongoing SARS-CoV-2 (COVID-19) outbreak has taken thousands of lives and the number of infections is growing daily. It become the largest threat to public health. Single-cell omics technologies are valuable tools for the characterization of the transcriptional changes and gene expression differences after SARS-CoV-2 infection. As an unparalleled single cell omics service provider, Creative Biolabs provides tailored single-cell sequencing and analyses solutions to accelerate SARS-CoV-2 (COVID-19) research and therapy development.